Objective: Surgical site infections (SSI) are a significant cause of maternal morbidity and rank third among infections requiring hospitalization. This study aimed to determine patients' clinical and laboratory outcomes with post-cesarean section surgical site infections during the peak COVID-19 era.
Method: Sixty patients who developed surgical site infections after cesarean section were included in the study retrospectively. They were divided into two groups. Thirty patient pandemic group recruited at the peak of COVID-19 were accepted, and thirty patients recruited in previous years were considered the pre-pandemic group. Age, parity, presence of comorbidity, emergency or elective cesarean section, use of drain in operation, postoperative hemoglobin, hematocrit and leukocyte values, presence of superficial or deep incisional infection, time from discharge to wound development, wound growth culture, antibiotic duration, length of hospital stay, and suture/non-suture performed were analyzed between the two groups.
Results: While superficial incisional infection was observed in 71.7% (n=43) of the patients with SSI, deep incisional infection was observed in 28.3% (n=17). Although there was an increase in the frequency of deep incisional infections with the pandemic, it did not reach a significant difference (p=0,390). There was no significant difference in hemoglobin, hematocrit, and leukocyte values. However, it was observed that all patients with deep incisional infections were sutured (p
Key words: Cesarean section; pandemic; surgical site infections; morbidity
|
